Autologous hematopoietic stem cell transplantation in multiple sclerosis (AHSCT-IN-MS): the zurich experience 24 months after approval

被引：0

作者：

Jelcic, I. ^{[1
]}

Mueller, A. ^{[1
]}

Hilty, M. ^{[1
]}

Wolfensberger, N. ^{[1
]}

Stathopoulos, P. ^{[1
]}

Ruder, J. ^{[1
]}

Thesenvitz, A. ^{[1
]}

Ritter, K. ^{[1
]}

Bachofner, A. ^{[1
]}

Foege, M. ^{[1
]}

Lutterotti, A. ^{[1
]}

Schanz, U. ^{[1
]}

Martin, R. ^{[1
]}

机构：

[1] Univ Hosp Zurich, Zurich, Switzerland

来源：

MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0295

引用

页码：262 / 263

页数：2

共 50 条

[1] Safety of autologous hematopoietic stem cell transplantation in multiple sclerosis patients (aHSCT-in-MS): the Zurich experience
Jelcic, I.
Mueller, A. M.
Stathopoulos, P.
Wolfensberger, N.
Thesenvitz, A.
Ritter, K.
Lutterotti, A.
Schanz, U.
Martin, R.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 380 - 380
[2] Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis
Creange, A.
Farge-Bancel, D.
[J]. REVUE NEUROLOGIQUE, 2008, 164 (03) : 207 - 215
[3] Autologous hematopoietic stem-cell transplantation (AHSCT)+/- consolidation therapy in multiple sclerosis (MS)
Shevchenko, Y. L.
Novik, A. A.
Kuznetsov, A. N.
Melnichenko, V. Y.
Fedorenko, D. A.
Ionova, T. I.
Kartashov, A. V.
Kurbatova, K. A.
Gorodokin, G.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 30 - 30
[4] Clinical outcomes of lymphoablative autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis (MS) patients
Fedorenko, D.
Nikolaev, I.
Kanshina, D.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 210 - 210
[5] Immunosuppressive therapy (IT) with autologous hematopoietic stem cell transplantation (AHSCT) as a new treatment modality in multiple sclerosis (MS)
Novik, A. A.
Afanasyev, B. V.
Lisukov, I. A.
Rykavicin, O. A.
Ionova, T. I.
Melnichenko, V. Y.
Fedorenko, D. A.
Kishtovich, A. V.
Kruglina, R. V.
Gorodokin, G. J.
[J]. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2008, 69 (03) : 145 - 145
[6] Immunosuppressive therapy (IT) with autologous hematopoietic stem cell transplantation (AHSCT) as a new treatment strategy in multiple sclerosis (MS)
Shevchenko, Y. L.
Novik, W. W.
Kuznetsov, W. N.
Afanasyev, B. V.
Lisukov, I. A.
Rykavicin, O. A.
Ionova, T. I.
Melnichenko, V. Y.
Fedorenko, D. A.
Kishtovich, A. V.
Kruglina, R. V.
Kondrashov, A. V.
Ivanov, R. A.
Gorodokin, G. J.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 27 - 27
[7] Immunosuppressive therapy (IT) with autologous hematopoietic stem cell transplantation (AHSCT) as a new treatment modality in multiple sclerosis (MS)
Novik, A. A.
Afanasyev, B. V.
Lisukov, I. A.
Rykavicin, O. A.
Ionova, T. I.
Melnichenko, V. Y.
Fedorenko, D. A.
Kishtovich, A. V.
Kruglina, R. V.
Gorodokin, G. J.
[J]. EXPERIMENTAL HEMATOLOGY, 2008, 36 (07) : S32 - S33
[8] Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
Mohammadi, Reihane
Aryan, Alisam
Omrani, Mir Davood
Ghaderian, Sayyed Mohammad Hossein
Fazeli, Zahra
[J]. BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 53 - 59
[9] MINI-AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT) ± CONSOLIDATION THERAPY IN THE POSTTRANSPLANT PERIOD FOR MULTIPLE SCLEROSIS (MS)
Novik, A.
Kuznetsov, A.
Melnichenko, V.
Fedorenko, D.
Ionova, T.
Kartashov, A.
Kurbatova, K.
Gorodokin, G.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 266 - 266
[10] Quality of life (QoL) assessment in multiple sclerosis (MS) patients undergoing autologous hematopoietic stem cell transplantation (AHSCT)
Fedorenko, D.
Nikolaev, I.
Kanshina, D.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 913 - 913

← 1 2 3 4 5 →